The SARS-CoV-2 viral genome encodes for 29 proteins—many of which could serve as potential targets for anti-viral drugs. In order to rapidly discover lead compounds for clinical use in the fight against COVID-19, an international team of scientists used a combination of approaches including structure-assisted drug design, virtual drug screening, and high-throughput screening. GEN
Wednesday, April 15, 2020
COVID-19 Drug Candidates Found by Targeting the Viral Protease
The SARS-CoV-2 viral genome encodes for 29 proteins—many of which could serve as potential targets for anti-viral drugs. In order to rapidly discover lead compounds for clinical use in the fight against COVID-19, an international team of scientists used a combination of approaches including structure-assisted drug design, virtual drug screening, and high-throughput screening. GEN
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment